Autobio Diagnostics Co., Ltd. (SHA:603658)

China flag China · Delayed Price · Currency is CNY
38.59
-0.19 (-0.49%)
Jun 4, 2025, 10:45 AM CST
-24.76%
Market Cap 22.31B
Revenue (ttm) 4.38B
Net Income (ttm) 1.14B
Shares Out 571.42M
EPS (ttm) 1.98
PE Ratio 19.72
Forward PE 17.98
Dividend 1.26 (3.23%)
Ex-Dividend Date May 26, 2025
Volume 725,700
Average Volume 1,839,025
Open 38.78
Previous Close 38.78
Day's Range 38.48 - 39.05
52-Week Range 37.56 - 52.98
Beta -0.10
RSI 43.20
Earnings Date Aug 21, 2025

About Autobio Diagnostics

Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products in China and internationally. The company offers immunoassay, biochemistry, and microbiology products; reagents and instruments; and technical and support, and training services, as well as engages in biology research and development activities. Its immunoassay products consist of AutoLumo S900 and AutoLumo A1860 that provides user experience for small and medium size labs; AutoLumo A6200/A6600, an auto... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Employees 5,773
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603658
Full Company Profile

Financial Performance

In 2024, Autobio Diagnostics's revenue was 4.47 billion, an increase of 0.62% compared to the previous year's 4.44 billion. Earnings were 1.19 billion, a decrease of -1.89%.

Financial Statements

News

There is no news available yet.